Ehp Funds Inc. Pfizer Inc Transaction History

Ehp Funds Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $26,130 - $33,940	1,000 Added 10.0%	11,000 $316,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $205,376 - $240,064	-6,400 Reduced 39.02%	10,000 $331,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $494,843 - $572,523	-13,700 Reduced 45.51%	16,400 $601,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.98 Million - $2.57 Million	-50,200 Reduced 62.52%	30,100 $1.23 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $288,075 - $376,050	-6,900 Reduced 7.91%	80,300 $4.12 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $131,280 - $160,260	3,000 Added 3.56%	87,200 $3.82 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.27 Million - $1.5 Million	27,200 Added 47.72%	84,200 $4.42 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $2.61 Million - $3.23 Million	57,000 New	57,000 $2.95 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ehp Funds Inc., based on Form 13F filings with the SEC.

Stay updated on Ehp Funds Inc. with notifications on news.